Hyperthermic intraperitoneal chemoperfusion with high dose oxaliplatin: Influence of perfusion temperature on postoperative outcome and survival

Introduction : Hyperthermic intraperitoneal chemotherapy (HIPEC) is becoming a standard therapy in the treatment of peritoneal carcinomatosis (PC). Compared to systemic chemotherapy, HIPEC improves survival in patients with PC. This therapy has high morbidity rates (up to 41%). In vitro it has been...

Descripción completa

Detalles Bibliográficos
Autor principal: Verhulst, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743150/
https://www.ncbi.nlm.nih.gov/pubmed/26913184
http://dx.doi.org/10.12688/f1000research.2-179.v2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743150/
https://www.ncbi.nlm.nih.gov/pubmed/26913184
http://dx.doi.org/10.12688/f1000research.2-179.v2

Ejemplares similares